RBC raised the price target on Regeneron Pharmaceuticals on July 7, 2025.

The entities involved

• Regeneron Pharmaceuticals →

  American pharmaceutical company

  • Andrew J. Murphy has been appointed Co-Chief Scientific Officer at Regeneron Pharmaceuticals.Sat 20:53
• Royal Bank of Canada →

  financial institution in Canada

  • Royal Bank of Canada adjusted its holdings in the Simplify Hedged Equity ETF on October 22, 2026.11:33
  • RBC lifted its position in Zeta Global, while Freedom Capital lowered its rating, and Bank of America raised its stake and price objective.11:05

Related events

• Royal Bank of Canada raised its price target on Webster Financial on July 2, 2025.Jun 8
• Royal Bank of Canada lifted its target price for Aurinia Pharmaceuticals Inc. on October 9, 2026.Oct 10
• Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.Tue 10:23
• RBC decreased target price and rating on fund (Q5908002), while TD Cowen restated its rating on shares.Jul 1
• Royal Bank of Canada raised its price target on CBS stock, concurrent with MarketBeat reporting the average rating for the company.Oct 6